Add Yahoo as a preferred source to see more of our stories on Google. Current treatments sometimes fail to help people with "wet" age-related macular degeneration -- and researchers now think they ...

Please provide your email address to receive an email when new articles are posted on . Sura-vec injection reduced the annualized anti-VEGF injection rate by 76% with a high dose and 77% with a low ...

Robot-guided radiation therapy can be an effective treatment for age-related macular degeneration (AMD), according to a study published Tuesday in The Lancet. The targeted radiation treatment reduced ...

– Susvimo is the only continuous delivery treatment to provide reliable, long-term vision outcomes in wet AMD, the leading cause of vision loss in people over the age of 60 – – With two refills per ...

A single injection of the tyrosine kinase inhibitor hydrogel has demonstrated superiority to aflibercept 2 mg in maintaining visual acuity and providing higher rescue-free rates through 1 year in ...

Credit: Genentech. In 2022, a voluntary recall was initiated due to some Susvimo implants not performing to Company standards. Genentech is reintroducing Susvimo ® (ranibizumab), a refillable ocular ...

Textile artist Jeanne Hewell-Chambers shares how trust, advocacy, and quirky support turned her fears about a wet AMD clinical trial into stable vision and reclaimed independence. Jeanne ...

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

When ophthalmologist Richard B. Rosen, MD, of New York Eye and Ear Infirmary of Mount Sinai in New York City, started his career more than 30 years ago, advanced age-related macular degeneration (AMD) ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new, five-year efficacy, safety and durability data from the Phase ...